← Hunan Haili Chemical overview

Hunan Haili Chemical vs FMC: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Hunan Haili Chemical Co Ltd (600731.CG)

Q3 2026
▲3▼1

Hunan Haili: Shareholder Buying, Capacity Expansion, But Profit Slumps

  • Controlling shareholder's buyback plan Hunan Haili's controlling shareholder plans to buy 85–170 million yuan of shares over 12 months, signaling confidence and putting a floor under the stock price.

    This is a major new capital action that directly supports the share price.

  • Controlling shareholder increases stake Haili Group bought 1.6177 million shares, raising its ownership to 24%. The purchase was funded by its own cash and a bank loan, showing strong commitment.

    This is a concrete follow-through on the buyback plan and a new positive signal.

  • New green pesticide production facility A controlling subsidiary will invest 22.8 million yuan in a smart facility to produce 4,000 tonnes per year of green pesticide formulations, expanding capacity and product range.

    This is a new capital investment that could boost future revenue and competitiveness.

  • First-half profit plunges on price pressure Hunan Haili's first-half net profit fell 45% to 78.89 million yuan as pesticide prices dropped and competition intensified. Second-quarter profit fell even more, down 60.5%.

    This is the key negative fundamental driver that weighs on the stock price.

August 2026
▲3▼1

Hunan Haili: Shareholder Buying, Capacity Expansion, But Profit Slumps

  • Controlling shareholder's buyback plan Hunan Haili's controlling shareholder plans to buy 85–170 million yuan of shares over 12 months, signaling confidence and putting a floor under the stock price.

    This is a major new capital action that directly supports the share price.

  • Controlling shareholder increases stake Haili Group bought 1.6177 million shares, raising its ownership to 24%. The purchase was funded by its own cash and a bank loan, showing strong commitment.

    This is a concrete follow-through on the buyback plan and a new positive signal.

  • New green pesticide production facility A controlling subsidiary will invest 22.8 million yuan in a smart facility to produce 4,000 tonnes per year of green pesticide formulations, expanding capacity and product range.

    This is a new capital investment that could boost future revenue and competitiveness.

  • First-half profit plunges on price pressure Hunan Haili's first-half net profit fell 45% to 78.89 million yuan as pesticide prices dropped and competition intensified. Second-quarter profit fell even more, down 60.5%.

    This is the key negative fundamental driver that weighs on the stock price.

Latest
▲3▼1

Hunan Haili: Shareholder Buying, Capacity Expansion, But Profit Slumps

  • Controlling shareholder's buyback plan Hunan Haili's controlling shareholder plans to buy 85–170 million yuan of shares over 12 months, signaling confidence and putting a floor under the stock price.

    This is a major new capital action that directly supports the share price.

  • Controlling shareholder increases stake Haili Group bought 1.6177 million shares, raising its ownership to 24%. The purchase was funded by its own cash and a bank loan, showing strong commitment.

    This is a concrete follow-through on the buyback plan and a new positive signal.

  • New green pesticide production facility A controlling subsidiary will invest 22.8 million yuan in a smart facility to produce 4,000 tonnes per year of green pesticide formulations, expanding capacity and product range.

    This is a new capital investment that could boost future revenue and competitiveness.

  • First-half profit plunges on price pressure Hunan Haili's first-half net profit fell 45% to 78.89 million yuan as pesticide prices dropped and competition intensified. Second-quarter profit fell even more, down 60.5%.

    This is the key negative fundamental driver that weighs on the stock price.

FMC Corporation (FMC)

Q3 2026
▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

  • Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.

    The guidance cut is the main new negative force on FMC's price this period.

  • Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.

    Debt reduction is the key positive force behind the period's sharp share rally.

  • New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.

    The Brazil filing is a new pipeline event that supports FMC's long-term growth story.

  • Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.

    Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.

September 2026
▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

  • Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.

    The guidance cut is the main new negative force on FMC's price this period.

  • Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.

    Debt reduction is the key positive force behind the period's sharp share rally.

  • New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.

    The Brazil filing is a new pipeline event that supports FMC's long-term growth story.

  • Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.

    Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.

Latest
▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

  • Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.

    The guidance cut is the main new negative force on FMC's price this period.

  • Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.

    Debt reduction is the key positive force behind the period's sharp share rally.

  • New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.

    The Brazil filing is a new pipeline event that supports FMC's long-term growth story.

  • Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.

    Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.